Infection and Immunity · 2004 · 50 citations · 21 references
Veterinary MedicineInfectious DiseasesMicrobiologyHost-pathogen InteractionsImmunizationVaccinologyAntigen DesignRecombinant Protein VaccinesRecombinant Vaccine DevelopmentVaccinationVaccine Antigen DesignVaccine Antigen DiscoveryBacterial Outer Membrane Protein EngineeringBacterial Vaccine AntigensCross-protective ImmunityIntraperitoneal AdministrationMeningococcal ProphylaxisOuter Membrane ProteinsOuter Membrane StructureOuter Membrane Vesicle Vaccine
Commensal neisseriae share with Neisseria meningitidis (meningococcus) a tendency towards overproduction of the bacterial outer envelope, leading to the formation and release during growth of outer membrane vesicles (OMVs). OMVs from both meningococci and commensal neisseriae have shown promise as vaccines to protect against meningococcal disease. We report here the successful expression at high levels of heterologous proteins in commensal neisseriae and the display, in its native conformation, of one meningococcal outer membrane protein vaccine candidate, NspA, in OMVs prepared from such a recombinant Neisseria flavescens strain. These NspA-containing OMVs conferred protection against otherwise lethal intraperitoneal challenge of mice with N. meningitidis serogroup B, and sera raised against them mediated opsonophagocytosis of meningococcal strains expressing this antigen. This development promises to facilitate the design of novel vaccines containing membrane protein antigens that are otherwise difficult to present in native conformation that provide cross-protective efficacy in the prevention of meningococcal disease.
21
Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal Vaccines
Jordan W. Tappero, A. Maldonado Ballesteros, D Williams et al. · JAMA · 1999 · 371 citations